Citigroup’s Bionano Genomics BNGO Stock Holding History

Citigroup’s Portfolio BNGO Stock Details BNGO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$3	Buy	3 +2	+200%	+$2	﹤0.01%	5634
2026 Q1	$1	Buy	+1	New	+$1	﹤0.01%	5851
2025 Q1	–	Sell	-117	Closed	-$2.03K	–	5603
2024 Q4	$2.03K	Hold	117	–	–	﹤0.01%	5546
2024 Q3	$3.19K	Hold	117	–	–	﹤0.01%	5379
2024 Q2	$4.76K	Hold	117	–	–	﹤0.01%	5262
2024 Q1	$7.8K	Hold	117	–	–	﹤0.01%	5255
2023 Q4	$13.3K	Sell	117 -75	-39%	-$7.83K	﹤0.01%	5123
2023 Q3	$34.9K	Sell	192 -14	-7%	-$3.67K	﹤0.01%	4245
2023 Q2	$75.3K	Buy	206 +42	+26%	+$19K	﹤0.01%	4378
2023 Q1	$109K	Sell	164 -13	-7%	-$11.5K	﹤0.01%	3978
2022 Q4	$155K	Sell	177 -144	-45%	-$181K	﹤0.01%	3844
2022 Q3	$352K	Sell	321 -113	-26%	-$149K	﹤0.01%	3480
2022 Q2	$359K	Sell	434 -157	-27%	-$162K	﹤0.01%	3467
2022 Q1	$915K	Sell	591 -115	-16%	-$155K	﹤0.01%	3056
2021 Q4	$1.27M	Buy	706 +59	+9%	+$158K	﹤0.01%	3003
2021 Q3	$2.13M	Hold	647	–	–	﹤0.01%	2495
2021 Q2	$2.85M	Buy	647 +160	+33%	+$632K	﹤0.01%	2384
2021 Q1	$2.36M	Buy	+487	New	+$2.75M	﹤0.01%	2389

Other funds holding BNGO

GCP

GSA Capital Partners London, United Kingdom $1.59B AUM 39.81% 1-Year Est. Return

CAM

Carret Asset Management New York $1.14B AUM 35.33% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return

Prudential Financial Newark, New Jersey $91.8B AUM 38.24% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

XTX Topco George Town, Cayman Islands $7.72B AUM 32.88% 1-Year Est. Return

Citigroup's BNGO Position: Q2 2026 in Review

Citigroup increased its Bionano Genomics (BNGO) stake by 200% in Q2 2026, buying an estimated $2 and bringing the position to 3 shares worth $3. The position accounts for ﹤0.01% of the portfolio, ranked #5634.

Citigroup first reported a position in BNGO in Q1 2021 and has held it in 18 quarters since. The position peaked at $2.85M in Q2 2021. 34 funds tracked by Wall St. Rank hold BNGO as of Q2 2026.

Citigroup held 3 shares of Bionano Genomics worth $3 as of Q2 2026.
Citigroup bought 2 Bionano Genomics shares in Q2 2026, an estimated $2.
Bionano Genomics made up ﹤0.01% of Citigroup's portfolio in Q2 2026, its #5634 holding.
Citigroup first reported a position in Bionano Genomics in Q1 2021 and has held it in 18 quarters since.
Citigroup's Bionano Genomics position peaked at $2.85M in Q2 2021.
34 funds tracked by Wall St. Rank held Bionano Genomics as of Q2 2026.

Based on Citigroup's 13F filing for Q2 2026, filed 3 Aug 2026.